Back to search
FDAFDA · Food and drugs·Recall number D-101-2013

Levothroid (levothyroxine sodium tablets, USP), 50 mcg., 100-count bottles, Rx only, NDC 0456-1321-01, Manufactured for Forest Pharmaceuticals, Inc., Subsidiary of Forest Laboratories, Inc., St. Louis, MO, by Lloyd Pharmaceutical, Shenandoah, IA.

Published January 2, 2013 · Recall initiated: July 25, 2012

Summary

FDA records drug Class II recall D-101-2013, published January 2, 2013 and initiated July 25, 2012. Recalling firm: Lloyd Inc. of Iowa; Status: Terminated; Reported quantity: 37,441/100-tablet bottles; Lot: Lot 1093992 and 1094095, exp. date 9/2012. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Subpotent; 9-month stability interval

What to do

Voluntary: Firm initiated · Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Lloyd Inc. of Iowa
Distributor
Distribution was nationwide and to Puerto Rico. There was no foreign, military, or government distribution.
Lot
Lot 1093992 and 1094095, exp. date 9/2012
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Levothroid (levothyroxine sodium tablets, USP), 50 mcg., 100-count bottles, Rx only, NDC 0456-1321-01, Manufactured for Forest Pharmaceuticals, Inc., Subsidiary of Forest Laboratories, Inc., St. Louis, MO, by Lloyd Pharmaceutical, Shenandoah, IA. recalled?

Yes. FDA published recall D-101-2013 on January 2, 2013. Reported hazard: Subpotent; 9-month stability interval

What should I do if I have this product?

Voluntary: Firm initiated · Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit